Background: While it is known that CD123 is normally strongly expressed on plasmacytoid dendritic cells and completely absent on nucleated red blood cells, detailed information regarding CD123 expression in acute leukemia is scarce and, if available, hard to compare due to different methodologies. Methods: CD123 expression was evaluated using standardized EuroFlow immunophenotyping in 139 pediatric AML, 316 adult AML, 193 pediatric BCP-ALL, 69 adult BCP-ALL, 101 pediatric T-A
This study was aimed to investigate the characteristics of CD123 expression on CD34(+)CD19(+) cells ...
Abstract Background Acute myeloid leukemia (AML) is a heterogeneous clonal disorder presenting with ...
SummaryLeukemia stem cells (LSCs) initiate and sustain the acute myeloid leukemia (AML) clonal hiera...
Background: While it is known that CD123 is normally strongly expressed on plasmacytoid dendritic ce...
Background: The genomic alterations in acute myeloid leukemia (AML) affect the function of signaling...
In spite of consistent progress at the level of basic research and of clinical treatment, acute myel...
Background: Leukemic stem cells (LSCs) are thought to originate either from normal hematopoietic ste...
NPM1-mutated (NPM1mut) acute myeloid leukemia (AML) comprises about 30% of newly diagnosed AML in ad...
The study was aimed to investigate the role and significance of CD123 with other immunological marke...
BACKGROUND AND OBJECTIVES: CD123 is an antibody that identifies the a chain of the human interleuki...
Prawidłowy przebieg hematopoezy jest niezbędny do utrzymania homeostazy naszego organizmu. Jednym ze...
The work was supported by grants to PH from The Danish Cancer Society, The Danish MRC, The John and ...
AC133 is a novel 5-transmembrane antigen present on a CD34((bright)) subset of human hematopoietic s...
High expression of the α chain of the interleukin-3 receptor (IL-3Rα; CD123) is a hallmark of acute ...
On behalf of the EuroFlow Consortium.[Background]: Optimal discrimination between leukemic blasts an...
This study was aimed to investigate the characteristics of CD123 expression on CD34(+)CD19(+) cells ...
Abstract Background Acute myeloid leukemia (AML) is a heterogeneous clonal disorder presenting with ...
SummaryLeukemia stem cells (LSCs) initiate and sustain the acute myeloid leukemia (AML) clonal hiera...
Background: While it is known that CD123 is normally strongly expressed on plasmacytoid dendritic ce...
Background: The genomic alterations in acute myeloid leukemia (AML) affect the function of signaling...
In spite of consistent progress at the level of basic research and of clinical treatment, acute myel...
Background: Leukemic stem cells (LSCs) are thought to originate either from normal hematopoietic ste...
NPM1-mutated (NPM1mut) acute myeloid leukemia (AML) comprises about 30% of newly diagnosed AML in ad...
The study was aimed to investigate the role and significance of CD123 with other immunological marke...
BACKGROUND AND OBJECTIVES: CD123 is an antibody that identifies the a chain of the human interleuki...
Prawidłowy przebieg hematopoezy jest niezbędny do utrzymania homeostazy naszego organizmu. Jednym ze...
The work was supported by grants to PH from The Danish Cancer Society, The Danish MRC, The John and ...
AC133 is a novel 5-transmembrane antigen present on a CD34((bright)) subset of human hematopoietic s...
High expression of the α chain of the interleukin-3 receptor (IL-3Rα; CD123) is a hallmark of acute ...
On behalf of the EuroFlow Consortium.[Background]: Optimal discrimination between leukemic blasts an...
This study was aimed to investigate the characteristics of CD123 expression on CD34(+)CD19(+) cells ...
Abstract Background Acute myeloid leukemia (AML) is a heterogeneous clonal disorder presenting with ...
SummaryLeukemia stem cells (LSCs) initiate and sustain the acute myeloid leukemia (AML) clonal hiera...